The effects of valbenazine on tardive dyskinesia in older and younger patients

OBJECTIVE: To evaluate the effects of once‐daily valbenazine (40 or 80 mg/d) in older and younger adults with tardive dyskinesia (TD). METHODS: Data were pooled from three 6‐week, randomized, double‐blind, placebo‐controlled (DBPC) studies (KINECT [NCT01688037], KINECT 2 [NCT01733121], and KINECT 3...

Descripción completa

Detalles Bibliográficos
Autores principales: Sajatovic, Martha, Alexopoulos, George S., Burke, Joshua, Farahmand, Khodayar, Siegert, Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916547/
https://www.ncbi.nlm.nih.gov/pubmed/31617235
http://dx.doi.org/10.1002/gps.5218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916547/
https://www.ncbi.nlm.nih.gov/pubmed/31617235
http://dx.doi.org/10.1002/gps.5218

Ejemplares similares